{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:35:49Z","timestamp":1789659349727,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-024-20585-8","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T04:13:06Z","timestamp":1731903186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Trends of drug-resistant tuberculosis and risk factors to poor treatment-outcome: a database analysis in Littoral region-Cameroon, 2013\u20132022"],"prefix":"10.1186","volume":"24","author":[{"given":"Teyim Pride","family":"Mbuh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mendjime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene-Adeline","family":"Goupeyou-Wandji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie Flore","family":"Donkeng-Donfack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Kahou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent-Mireille","family":"Endale Mangamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Mefoug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Annie","family":"Bisso Ngono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Esso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges Alain","family":"Etoundi Mballa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"issue":"4","key":"20585_CR1","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1128\/CMR.00061-05","volume":"19","author":"B Mathema","year":"2006","unstructured":"Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev. 2006;19(4):658\u201385.","journal-title":"Clin Microbiol Rev"},{"key":"20585_CR2","unstructured":"Direction de Lutte contre la Maladie. Guide Technique pour la surveillance int\u00e9gr\u00e9e de la maladie et riposte. 2020;75. http:\/\/www.luttecontrelamaladie.org\/"},{"key":"20585_CR3","unstructured":"Care C. Making Sense of TB data Guide for collection, analysis and use of TB data for health workers in Zimbabwe [Internet]. 2017 p. 43\u201355. https:\/\/www.kncvtbc.org\/uploaded\/2017\/08\/Making_Sense_of_TB_Data.pdf"},{"key":"20585_CR4","unstructured":"Cock KM, De, Dworkin MS. HIV infection and TB. 1998."},{"key":"20585_CR5","unstructured":"WHO. Frequently asked questions about TB and HIV. 2012;5. http:\/\/www.who.int\/tb\/challenges\/hiv\/faq\/en\/"},{"key":"20585_CR6","unstructured":"WHO, Global TB. report. 2022. 1\u201314 p."},{"key":"20585_CR7","unstructured":"The Economist Intelligence Unit. It \u2019s Time to End Drug-Resistant Tuberculosis. The case for action. 2019;1\u201339. http:\/\/www.eiu.com\/graphics\/marketing\/pdf\/its-time-to-end-drug-resistant-tuberculosis-full-report.pdf"},{"key":"20585_CR8","unstructured":"WHO. What is multidrug-resistant tuberculosis (MDR-TB) and how do we control it? 2018."},{"key":"20585_CR9","unstructured":"WHO. Global tuberculosis control. 2016."},{"key":"20585_CR10","unstructured":"WHO, Global TB, Report. Drug-resistant TB [Internet]. 2022. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2022\/tb-disease-burden\/2-3-drug-resistant-tb"},{"key":"20585_CR11","unstructured":"WHO, Global TB. report. Who [Internet]. 2022;XXXIII(2):81\u20137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15003161%5Cnhttp:\/\/cid.oxfordjournals.org\/lookup\/doi\/10.1093\/cid\/cir991%5Cnhttp:\/\/www.scielo.cl\/pdf\/udecada\/v15n26\/art06.pdf%5Cnhttp:\/\/www.scopus.com\/inward\/record.url?eid=2-s2.0-84861150233&partnerID=tZOtx3y1"},{"key":"20585_CR12","unstructured":"Kodjin. Data Analytics in Healthcare: Challenges and Uses [Internet]. 2024. https:\/\/kodjin.com\/blog\/data-analytics-in-healthcare-challenges-and-solutions\/"},{"key":"20585_CR13","doi-asserted-by":"publisher","unstructured":"Alene KA, Xu Z, Bai L, Yi H, Tan Y, Gray D et al. Spatial clustering of drug- \u00ad resistant tuberculosis in Hunan Province. China: Ecol Study. 2021;11:e043685. https:\/\/doi.org\/10.1136\/bmjopen-2020-043685.","DOI":"10.1136\/bmjopen-2020-043685"},{"key":"20585_CR14","unstructured":"WHO. Tuberculosis in the WHO African Region: 2023 progress update. Tuberc WHO African Reg 2023 Prog Updat. 2023;(September)."},{"key":"20585_CR15","doi-asserted-by":"publisher","unstructured":"Kalil FS, Abdulle MS. Evaluation of measles surveillance systems in Ginnir District, Bale Zone, Southeast Ethiopia: a concurrent embedded mixed quantitative. Qualitative Study. 2021;14:997\u20131008. https:\/\/doi.org\/10.2147\/RMHP.S295889","DOI":"10.2147\/RMHP.S295889"},{"key":"20585_CR16","doi-asserted-by":"publisher","unstructured":"Datiko D, Hadgu A, Jerene D, Suarez PG. High urban tuberculosis case notification rates can be misleading: evidence from an urban setting in Ethiopia. BMC Public Health 2020;20:302. https:\/\/doi.org\/10.1186\/s12889-020-8290-z","DOI":"10.1186\/s12889-020-8290-z"},{"key":"20585_CR17","unstructured":"National Tuberculosis Control Program. National tuberculosis control program annual report. 2023 p. 1\u201343."},{"key":"20585_CR18","doi-asserted-by":"publisher","unstructured":"Mbuh TP, Wandji A, Keugni L, Mboh S, Ane-anyangwe I, Mbacham WF et al. Predictors of Drug-Resistant Tuberculosis among High-Risk Population Diagnosed under National Program Conditions in the Littoral Region, Cameroon. Biomed Res Int [Internet]. 2021;2021. https:\/\/doi.org\/10.1155\/2021\/8817442","DOI":"10.1155\/2021\/8817442"},{"key":"20585_CR19","doi-asserted-by":"publisher","unstructured":"Gadallah M, Amin W, Rady M. Household catastrophic total cost due to tuberculosis in Egypt: incidence, cost drivers and policy implication. East Mediterr Health Journal. 2022;28(7):489\u201397. https:\/\/doi.org\/10.26719\/emhj.22.049.","DOI":"10.26719\/emhj.22.049"},{"key":"20585_CR20","doi-asserted-by":"publisher","unstructured":"Kouam AF, Auguste N, Ngoum\u00e9 N, Gaelle A, Fepa K, Wainfen Z et al. Liver injury in malaria infected patients in Douala \u2013 Cameroon and its association with poor medical practice. Egypt Liver J [Internet]. 2023; https:\/\/doi.org\/10.1186\/s43066-023-00300-9","DOI":"10.1186\/s43066-023-00300-9"},{"key":"20585_CR21","unstructured":"Tb M-, Tb X-, Africa S, Drug T, Tuberculosis R. Drug resistant tuberculosis: Challenges of urbanization. 2025;3:2010\u20132."},{"key":"20585_CR22","doi-asserted-by":"publisher","unstructured":"Noykhovich E. The risk of tuberculosis among populations living in Slum settings: a systematic review and Meta-analysis. J Urban Health . 201996(2):262\u201375. https:\/\/doi.org\/10.1007\/s11524-018-0319-6.","DOI":"10.1007\/s11524-018-0319-6"},{"key":"20585_CR23","doi-asserted-by":"publisher","unstructured":"Low C-T, Lee P-CLaW-SCTC-KTH. P-KH. No TitleExploring tuberculosis by types of housing development. Soc Sci Med [Internet]. 2013;87(June):77\u201383. https:\/\/doi.org\/10.1016\/j.socscimed.2013.03.024","DOI":"10.1016\/j.socscimed.2013.03.024"},{"key":"20585_CR24","unstructured":"Organization WH. UN-HABITAT. Global report on urban health equitable, healthier cities for sustainable development. 2016 p. 241."},{"key":"20585_CR25","doi-asserted-by":"publisher","unstructured":"Mbuh TP, Ane-anyangwe I, Adeline W, Pokam BDT, Meriki HD, Mbacham WF. Bacteriologically confirmed extra pulmonary tuberculosis and treatment outcome of patients consulted and treated under program conditions in the littoral region of Cameroon. BMC Pulm Med. 2019;19(1):17. https:\/\/doi.org\/10.1186\/s12890-018-0770-x.","DOI":"10.1186\/s12890-018-0770-x"},{"key":"20585_CR26","unstructured":"World Health Organisation. Global tuberculosis report [Internet]. 2022. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2022\/tb-diagnosis-treatment\/3-4-drug-resistant-tb-treatment"},{"key":"20585_CR27","doi-asserted-by":"publisher","unstructured":"Communication B. Reasons for refusal among patients with tuberculosis and their household contacts to participate in an observational cohort study. Perspect Clin Res. 2021;12(4):234\u2013235. https:\/\/doi.org\/10.4103\/picr.picr_377_20","DOI":"10.4103\/picr.picr_377_20"},{"key":"20585_CR28","doi-asserted-by":"publisher","unstructured":"Skinner D, Claassens M. It \u2019 s complicated: why do tuberculosis patients not initiate or stay adherent to treatment ? A qualitative study from South Africa. BMC Infect Dis [Internet]. 2016;1\u20139. https:\/\/doi.org\/10.1186\/s12879-016-2054-5","DOI":"10.1186\/s12879-016-2054-5"},{"key":"20585_CR29","doi-asserted-by":"publisher","unstructured":"Song Y, Tan J, Chen T, Deng G. Challenges faced by Multidrug-resistant tuberculosis patients in three financially. Risk Manag Healthc Policy. 2020;13:2387\u2013394. https:\/\/doi.org\/10.2147\/RMHP.S275400.","DOI":"10.2147\/RMHP.S275400"},{"key":"20585_CR30","doi-asserted-by":"publisher","unstructured":"Kizito E, Musaazi J, Mutesasira K, Twinomugisha F, Namwanje H, Kiyemba T et al. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study. BMC Infect Dis. 2021;21(1):292. https:\/\/doi.org\/10.1186\/s12879-021-05967-2.","DOI":"10.1186\/s12879-021-05967-2"},{"key":"20585_CR31","doi-asserted-by":"publisher","unstructured":"Chung-delgado K, Guillen-bravo S, Revilla-montag A, Bernabe-ortiz A. Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and Associated factors. PLoS One. 2015;10(3):e0119332. https:\/\/doi.org\/10.1371\/journal.pone.0119332.","DOI":"10.1371\/journal.pone.0119332"},{"key":"20585_CR32","doi-asserted-by":"publisher","unstructured":"Anderson K, Pietersen E, Shepherd BE, Bian A, Dheda K, Warren R et al. High mortality among patients hospitalized for drug- resistant tuberculosis with acquired second-line drug resistance and high HIV prevalence. HIV Med. 2022;23(10):1085\u20131097. https:\/\/doi.org\/10.1111\/hiv.13318.","DOI":"10.1111\/hiv.13318"},{"key":"20585_CR33","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.5588\/ijtld.15.0731","volume":"20","author":"BHM Ngahane","year":"2016","unstructured":"Ngahane BHM, Dahirou F, Tchieche C, Wandji A, Mangamba MLE, Kuaban C. Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study. Int J Tuberc Lung Dis. 2016;20(12):1609\u20131614. https:\/\/doi.org\/10.5588\/ijtld.15.0731.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"20585_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0115211","volume":"9","author":"AA Agbor","year":"2014","unstructured":"Agbor AA, Bigna JJR, Billong SC, Tejiokem MC, Ekali GL, Plottel CS, et al. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaounde Central Hospital, Cameroon: an 8-Year hospital-based Retrospective Cohort Study (2006\u20132013). PLoS One. 2014;9(12):e115211. https:\/\/doi.org\/10.1371\/journal.pone.0115211.","journal-title":"PLoS ONE"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-20585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-20585-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-20585-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T10:05:04Z","timestamp":1732097104000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-20585-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["20585"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-20585-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Since this was a database analysis where we didn\u2019t have any contact with the patients or their specimens, it wasn\u2019t possible for us to obtain participants\u2019 consent. We also judge it is not obligatory to obtain ethical clearance. We however obtained administrative authorization from the Ministry of Public Health with decision number <b>N<\/b><sup><b>o<\/b><\/sup><b>04671\/L\/MINSANTE\/SG\/CCOUSP<\/b> to evaluate the drug-resistant tuberculosis database analysis in the Littoral Region-Cameroon, 2013\u20132022. Participant information was anonymized by assigning a unique protocol number.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"3195"}}